Cushingoid lipodystrophy can be prevented by thiazolidinediones.
Eric
E
Winkel
Arick
A
Sabin
Rafael
R
Mejía-Alvarez
D000273:Adipose Tissue / Q000473:pathology; D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight / Q000502:physiology; D005234:Fatty Liver / Q000139:chemically induced / Q000378:metabolism; D005260:Female; D006854:Hydrocortisone / Q000494:pharmacology; D008060:Lipodystrophy / Q000517:prevention & control*; D008099:Liver / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D009929:Organ Size / Q000187:drug effects; D047748:Pituitary ACTH Hypersecretion / Q000517:prevention & control*; D045162:Thiazolidinediones / Q000627:therapeutic use*; D015430:Weight Gain / Q000502:physiology
D045162:Thiazolidinediones; D006854:Hydrocortisone